Seeking Alpha

Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day

MENLO PARK, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sight Sciences (SGHT), Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and ...
Nasdaq

Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate ...

The analysis published in Clinical Ophthalmology suggests that OMNI was as effective at lowering IOP and reducing medication usage in advanced glaucoma as it was in mild and moderate glaucoma. MENLO ...
Seeking Alpha

Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital

MENLO PARK, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative technology ...
Business Insider

Sight Sciences Reports Modest Growth and Optimistic Outlook

Sight Sciences, Inc. ( (SGHT)) has released its Q3 earnings. Here is a breakdown of the information Sight Sciences, Inc. presented to its investors. Sight Sciences, Inc. is an eyecare technology ...
NBC4 Columbus

Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma

MENLO PARK, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing ...